Intelligent Investor

Silex Systems Limited (ASX: SLX) - Announcements

Current share price for SLX : $4.785 0.175 (3.53%)

ASX company news and announcements for Silex Systems Limited (SLX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Silex Systems Limited (SLX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Silex Systems Limited (SLX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Silex Systems Limited (SLX)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$1,132 Application for quotation of securities - SLX 27 Mar 2024 5:57PM $4.830 $4.785 $5.110 fallen by 0.93%
$1,132 GLE Receives US NRC Approval to Load UF6 26 Mar 2024 8:44AM $4.830 $4.785 $5.110 fallen by 0.93%
$1,132 GLE's Evaluation of US DOE HALEU Enrichment Acquisition RFP 25 Mar 2024 9:15AM $4.840 $4.785 $5.110 fallen by 1.14%
$1,132 Cleansing Notice 29 Feb 2024 5:23PM $5.000 $4.785 $5.110 fallen by 4.30%
$1,132 Application for quotation of securities - SLX 29 Feb 2024 5:15PM $5.000 $4.785 $5.110 fallen by 4.30%
$1,132 Investor Presentation 22 Feb 2024 8:19AM $4.700 $4.785 $5.110 risen by 1.81%
$1,132 Operational Update - 22 February 2024 22 Feb 2024 8:19AM $4.700 $4.785 $5.110 risen by 1.81%
$1,132 Half Year Accounts (Appendix 4D) 22 Feb 2024 8:13AM $4.700 $4.785 $5.110 risen by 1.81%
$1,132 Continued Acceleration of GLE's Commercialisation Program 19 Feb 2024 8:15AM $4.780 $4.785 $5.110 risen by 0.10%
$1,132 Proposed issue of securities - SLX 23 Jan 2024 8:35AM $4.760 $4.785 $5.110 risen by 0.53%
$1,132 Silex and SQC Sign Expanded Commercial Arrangements 23 Jan 2024 8:23AM $4.760 $4.785 $5.110 risen by 0.53%
$1,132 U.S. DOE Releases HALEU Enrichment Request for Proposal 10 Jan 2024 8:45AM $4.050 $4.785 $5.110 risen by 18.15%
$1,132 Proof-of-Concept Completed for Medical Isotope Technology 20 Dec 2023 1:47PM $4.120 $4.785 $5.110 risen by 16.14%
$1,132 Notification regarding unquoted securities - SLX 19 Dec 2023 1:08PM $4.150 $4.785 $5.110 risen by 15.30%
$1,132 Release of Shares from Voluntary Escrow 13 Dec 2023 3:09PM $3.990 $4.785 $5.110 risen by 19.92%
$1,132 Investor Presentation 2 Nov 2023 8:50AM $3.300 $4.785 $5.110 risen by 45%
$1,132 Results of Meeting 13 Oct 2023 3:18PM $3.250 $4.785 $5.110 risen by 47.23%
$1,132 Silex AGM Presentation - 2023 13 Oct 2023 8:42AM $3.200 $4.785 $5.110 risen by 49.53%
$1,132 Chair's Address to Shareholders - 2023 AGM 13 Oct 2023 8:37AM $3.200 $4.785 $5.110 risen by 49.53%
$1,132 Application for quotation of securities - SLX 26 Sep 2023 4:57PM $3.400 $4.785 $5.110 risen by 40.74%
$1,132 Notice of Annual General Meeting/Proxy Form 11 Sep 2023 3:58PM $3.290 $4.785 $5.110 risen by 45.44%
$1,132 Annual Report to Shareholders 24 Aug 2023 5:34PM $3.380 $4.785 $5.110 risen by 41.57%
$1,132 Change of Director's Interest Notice 23 Aug 2023 6:12PM $3.560 $4.785 $5.110 risen by 34.41%
$1,132 Notification regarding unquoted securities - SLX 23 Aug 2023 5:48PM $3.560 $4.785 $5.110 risen by 34.41%
$1,132 Notification of cessation of securities - SLX 23 Aug 2023 5:45PM $3.560 $4.785 $5.110 risen by 34.41%

1 - 25 of 435 results

Page 1 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.